No blend-level human data: there is no registered clinical trial of the KLOW blend, so its combined safety profile is not established in humans
Carnitine supplementation to obese Zucker rats prevents obesity-induced type II to type I muscle fiber transition and favors an oxidative phenotype of skeletal muscle
These adjustments enhance medication effects and help patients build habits that last long after the titration phase ends
Compounding has long played an important role in healthcare, but it was not intended to replace the drug approval process
Beyond weight loss, GLP-1 agonists are thought to reduce inflammation, improve heart function, and even help with brain fog, offering a clearer path forward during a time that can feel uncertain and overwhelming
Epithalon, Epitalon and Epithalone: Are They the Same